Skip to main content

Meraki Protective Mist Sunscreen

NDC 87905-3019 · MERAKI MEDICAL SPA LLC

Generic nameBroad Spectrum SPF 30
Dosage formSPRAY
RouteTOPICAL
Active ingredient(s)OCTOCRYLENE, OCTISALATE, AVOBENZONE
Strength2.5; 3; 5 g/100g; g/100g; g/100g
Marketing categoryOTC MONOGRAPH DRUG

Packages

87905-3019-1 — 171 g in 1 CAN (87905-3019-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

87648-150 — HOMOSALATE, OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, 87669-963 — AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, 87675-949 — AVOBENZONE, OCTISALATE, OCTOCRYLENE, 87675-959 — AVOBENZONE, OCTISALATE, OCTOCRYLENE, 87679-020 — Avobenzone, Homosalate, Octisalate. Octocrylene, 87719-001 — Homosalate Octocrylene Ethylhexyl Salicylate, 87719-002 — Zinc Oxide Octocrylene Ethylhexyl Salicylate Homosalate Titanium Dioxide, 87729-150 — AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, 87746-150 — Avobenzone, Homosalate, Octisalate, Octocrylene, 87767-001 — Homosalate, Octocrylene, Octisalate, Avobenzone, 87770-005 — BROAD SPECTRUM SPF 50, 87770-006 — BROAD SPECTRUM SPF 50, 87820-150 — Homosalate, Octisalate, Octocrylene, Titanium Dioxide, 87838-002 — Titanium Dioxide and Zinc Oxide Sunscreen, 87849-9103 — Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, 87849-9301 — Avobenzone, Octinoxate, Octisalate, 87901-3019 — Broad Spectrum SPF 30, 87911-001 — Octocrylene 8%, Octisalate 5%, Titanium Dioxide 6%, Zinc Oxide 8%, 87911-002 — Octocrylene 8%, Octisalate 5%, Titanium Dioxide 6%, Zinc Oxide 8%, 87911-003 — Octocrylene 8%, Octisalate 5%, Titanium Dioxide 6%, Zinc Oxide 8%, +3708 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels